tiprankstipranks
Trending News
More News >

RYOIX Technical Analysis

Summary of all the Indicators

Summary
Sell
6Bullish
4Neutral
12Bearish
Oscillators
Neutral
3Bullish
4Neutral
3Bearish
Moving Averages
Strong Sell
3Bullish
0Neutral
9Bearish
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Rydex Series Trust Biotechnology Fund Investor Class is a Sell.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) 20-Day exponential moving average is 61.18, making it a Buy.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) 50-Day exponential moving average is 62.28, making it a Sell.

Rydex Series Trust Biotechnology Fund Investor Class (RYOIX) Pivot Points

May 22, 2025, 07:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
62.62
62.62
62.62
62.62
62.62
62.62
62.62
Fibonacci
62.62
62.62
62.62
62.62
62.62
62.62
62.62

Rydex Series Trust Biotechnology Fund Investor Class (RYOIX) Moving Averages

May 22, 2025, 07:14 AM
Period
Simple
Exponential
MA5
61.36Sell
61.36Sell
MA10
60.66Buy
61.15Buy
MA20
61.55Sell
61.18Buy
MA50
62.21Sell
62.28Sell
MA100
64.52Sell
64.00Sell
MA200
67.21Sell
65.97Sell
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) 10-Day exponential moving average is 61.15, making it a Buy.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) 100-Day exponential moving average is 64.00, making it a Sell.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) 50-day simple moving average is 62.21, creating a Sell signal.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) 100-day simple moving average is 64.52, creating a Sell signal.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) 200-day simple moving average is 67.21, creating a Sell signal.

Rydex Series Trust Biotechnology Fund Investor Class (RYOIX) Technical Analysis

May 22, 2025, 07:14 AM
Name
Value
Action
RSI (14)
49.45
Neutral
STOCH (9,6)
87.07
Sell
STOCHRSI (14)
57.74
Neutral
MACD (12,26)
-0.20
Sell
ADX (14)
11.21
Buy
Williams %R
-55.56
Buy
CCI (14)
-17.45
Neutral
ATR (14)
1.09
-
Ultimate Oscillator
48.71
Neutral
ROC
-3.26
Sell
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) Relative Strength Index (RSI) is 49.45, creating a Neutral signal.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) Trend Strength Indicator (ADX) is 11.21, creating a Buy signal.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) Commodity Channel Index (CCI) is -17.45, creating a Neutral signal.
Rydex Series Trust Biotechnology Fund Investor Class’s (RYOIX) Price Rate of Change (ROC) is -3.26, creating a Sell signal.

FAQ

Is RYOIX a Buy, Hold, or Sell?
Based on RYOIX’s technical indicators, RYOIX is a Sell.
    What is RYOIX’s RSI (14)?
    RYOIX’s RSI (14) is 49.45, which suggests RYOIX is a Neutral.
      What is RYOIX’s MACD?
      RYOIX’s MACD is -0.20, which suggests RYOIX is a Sell.
        What is RYOIX’s 5-day moving average?
        RYOIX’s 5-day moving average is 61.36, which suggests RYOIX is a Sell.
          What is RYOIX’s 20-day moving average?
          RYOIX 20-day moving average is 61.55, which suggests RYOIX is a Sell.
            What is RYOIX’s 50-day moving average?
            RYOIX’s 50-day moving average is 62.21, which suggests RYOIX is a Sell.
              What is RYOIX’s 200-day moving average?
              RYOIX’s 200-day moving average is 67.21, which suggests RYOIX is a Sell.
                What is RYOIX’s Williams % R (14)?
                RYOIX’s Williams % R (14) is -55.56, which suggests RYOIX is a Buy.
                  What is RYOIX’s CCI (14)?
                  RYOIX’s CCI (14) is -17.45, which suggests RYOIX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis